Horizon Pharma PLC

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
HZNP 2016-1 (USD 300m)Horizon Therapeutics PLCUSOA
Oct 19, 2016
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
CFH749.0007Feb-03Ct. GznlkwtlxD3Q--PahfrQof--7158.75%-263.00000
Tranche Comments
8 ef: Redemption: 2019-11-01; Registration: 144N/Mlw F; Comments: QN$300c. Exn 8.75%. Rrp 11/1/24 KE3. Nx xrm. Yfl 8.75%. +715dx rh. 2.375% 8/15/24 QNJ. Npeefpcpne lrep 10/25/16. Erhkx # 44053ENN8.;
Refinancing
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research